These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1968368)

  • 1. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
    Elliott WJ; Weber RR; Nelson KS; Oliner CM; Fumo MT; Gretler DD; McCray GR; Murphy MB
    Circulation; 1990 Mar; 81(3):970-7. PubMed ID: 1968368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.
    Reisin E; Huth MM; Nguyen BP; Weed SG; Gonzalez FM
    Hypertension; 1990 Feb; 15(2 Suppl):I59-62. PubMed ID: 1967592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension.
    White WB; Halley SE
    Arch Intern Med; 1989 Apr; 149(4):870-4. PubMed ID: 2565105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension.
    Pilmer BL; Green JA; Panacek EA; Elliot WJ; Murphy MB; Rutherford W; Nara AR
    J Clin Pharmacol; 1993 Jun; 33(6):549-53. PubMed ID: 8103527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery.
    Hill AJ; Feneck RO; Walesby RK
    J Cardiothorac Vasc Anesth; 1993 Jun; 7(3):279-84. PubMed ID: 8100152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenoldopam improves renal hemodynamics impaired by positive end-expiratory pressure.
    Poinsot O; Romand JA; Favre H; Suter PM
    Anesthesiology; 1993 Oct; 79(4):680-4. PubMed ID: 8105727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension.
    Hackman BB; Griffin B; Mills M; Ramanathan KB
    Am J Cardiol; 1992 Apr; 69(9):918-22. PubMed ID: 1347965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans.
    Elliott WJ; Karnezis TA; Silverman RA; Geanon J; Tripathi RC; Murphy MB
    Clin Pharmacol Ther; 1991 Mar; 49(3):285-93. PubMed ID: 1672512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
    Gretler DD; Elliott WJ; Moscucci M; Childers RW; Murphy MB
    Arch Intern Med; 1992 Dec; 152(12):2445-8. PubMed ID: 1360793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of renal blood flow during hypotension induced with fenoldopam in dogs.
    Aronson S; Goldberg LI; Roth S; Glock D; Moss J; Roizen MF
    Can J Anaesth; 1990 Apr; 37(3):380-4. PubMed ID: 1969772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs.
    Kien ND; Moore PG; Jaffe RS
    Anesth Analg; 1992 Jan; 74(1):72-8. PubMed ID: 1346487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous fenoldopam infusion in severe heart failure.
    Patel JJ; Mitha AS; Sareli P; de Vaal JB
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis.
    Bodmann KF; Tröster S; Clemens R; Schuster HP
    Clin Investig; 1993 Dec; 72(1):60-4. PubMed ID: 7907900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous fenoldopam (SK&F 82526-J) on blood pressure in severe hypertension. SK&F Fenoldopam Working Group.
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):445-6. PubMed ID: 1355665
    [No Abstract]   [Full Text] [Related]  

  • 19. Diuretic and natriuretic properties of fenoldopam in chronic renal failure.
    Andrés A; García-Robles R; Alcázar JM; Alvarez C; Martínez J; Oliet A; Sancho J; Rodicio JL; Ruilope LM
    J Hypertens Suppl; 1989 Dec; 7(6):S326-7. PubMed ID: 2576671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.